The invention relates to the technical field of
medicine, in particular to an N-
aryl anthranilamide acid compound anti-intracerebral tumor
active compound, preparation and application thereof, wherein the structural general formula is shown in the specification, R1 is one or more of
halogen F or Cl or Br or I,
alkyl, heteroalkane, amino and
nitryl, the substitution positions of R1 on a
benzene ring are 2-site, 3-site and 4-site, the number of substituents is monosubstitution or polysubstitution, R2 is one or more of
halogen F or Cl or Br or I,
alkyl, heteroalkane, amino and
nitryl, the substitution positions of R2 on the
benzene ring are 2-site, 3-site and 4-site, the number of substituents is monosubstitution or polysubstitution, R3 is a heterocyclic ring or a benzoheterocyclic ring, n is 1-3, and X is N or CH. The compound disclosed by the invention has a remarkable COX-2 inhibition effect and a
topoisomerase inhibition effect, has the effects of remarkably inhibiting proliferation,
invasion and migration of various tumors, especially brain tumors such as
glioma and the like
in vivo and
in vitro, retarding cycle and the like, and is a novel multi-target antitumor
drug.